arrow
J

Joachim Havla

ludwig-maximilian-university
H指数:40
被引数:6,536

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sex-specific analysis of early disease course and treatment in a German multiple sclerosis cohort

德国多发性硬化队列中早期疾病进程和治疗的性别特异性分析

2026-06-010
PRE
Prognostic value of evoked potentials for disease progression in early multiple sclerosis and clinically isolated syndrome in the prospective multicentre ProVal-MS study

早期多发性硬化及临床孤立综合征中诱发电位对疾病进展的预测价值:前瞻性多中心ProVal-MS研究

2026-04-140
PRE
Hyperreflective Foci in the Inner Nuclear Layer: Proof-of-Concept for an Optical Coherence Tomography Derived Microglia-Related Marker in Multiple Sclerosis

内核层高反射焦点:多发性硬化中基于光学相干断层扫描的微胶质细胞相关标记的概念验证

2026-04-070
OAAI
Age, Low Immunoglobulin G, and M Serum Levels Predict Infections in People With AQP4-IgG+ NMOSD Treated With Rituximab—A Multicenter Cohort Study From the German Neuromyelitis Optica Study Group (NEMOS)

年龄,低免疫球蛋白G和M血清水平可预测利妥昔单抗治疗的AQP4-IgG NMOSD患者的感染-德国视神经脊髓炎研究组 (NEMOS) 的一项多中心队列研究

2026-02-040
OAAI
External validation of a multiple sclerosis treatment decision score using data from the ProVal-MS cohort study

利用ProVal-MS队列研究数据对一种多发性硬化治疗决策评分进行外部验证

2025-11-210
OA
Lessons Learned: Quality Analysis of Optical Coherence Tomography in Neuromyelitis Optica
2025-11-010
OAAI
Genetic Risk Variants for Multiple Sclerosis and Other Loci Linked to Intrathecal Immunoglobulin G Synthesis

多发性硬化症的遗传风险变异和与鞘内免疫球蛋白G合成相关的其他基因座

2025-11-010
PRE
SV2A-PET imaging uncovers cortical synapse loss in multiple sclerosis

SV2A-PET成像揭示了多发性硬化中的皮层突触丢失

2025-10-011
PRE
HLA-A∗03:01 as predictive genetic biomarker for glatiramer acetate treatment response in multiple sclerosis: a retrospective cohort analysis

HLA-A∗03:01作为预测干扰素β治疗反应的遗传生物标志物在多发性硬化中的研究:一项回顾性队列分析

2025-07-310
PRE
Worse recovery from acute attacks and faster disability accumulation highlights the unmet need for improved treatment in patients with late-onset neuromyelitis optica spectrum disorders (COPTER-LO study)

急性发作后恢复更差以及残疾累积更快,突显了晚期发作视神经脊髓炎谱系障碍(COPTER-LO研究)患者对改进治疗的未满足需求。

2025-04-110
PRE
Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGAD

关于NMOSD和MOGAD免疫疗法的选择和有效性的真实世界多中心队列研究

2024-12-270
PRE
Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks
2024-11-040
OAAI